Micron Pure develops and licenses air and surface sanitation technologies that utilize a novel catalyst and ozone to inactivate 99.97% of airborne SARS-CoV-2 in a single pass, without releasing ozone into occupied spaces. This technology addresses the need for effective pathogen control in indoor environments, where airborne viruses can remain contagious for hours.
Funding
$15.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Indoor environments pose a significant risk for the transmission of airborne pathogens, including SARS-CoV-2, which can remain contagious for several hours. Existing air purification methods may not effectively eliminate these pathogens or may release harmful chemicals into occupied spaces. This necessitates new technologies to provide clean air and surfaces without exposing people to harmful chemicals.
Solution
Micron Pure develops and licenses air and surface sanitation technologies that utilize a novel catalyst and ozone to inactivate airborne pathogens. The core technology is designed to eliminate 99.97% of airborne SARS-CoV-2 in a single pass, without releasing ozone into occupied spaces, ensuring continuous use while people are present. This approach aims to reduce the risk of airborne transmission in various indoor settings. The technology is integrated into air purifiers, such as the CerroZone™ air purifier, to provide clean air and surfaces.
Target Audience
The primary target audience includes manufacturers of air purification systems, building managers, and individuals concerned about indoor air quality and pathogen transmission.
Features
- Utilizes a novel catalyst and ozone combination for air and surface sanitation.
- Inactivates 99.97% of airborne SARS-CoV-2 in a single pass.
- Designed to release zero ozone into occupied spaces, allowing for continuous use.
- Integrated into air purification systems like CerroZone™ air purifiers.
- Patent-pending designs and IP protected.